Virbac share falls 5.5%, lagging the SBF 120 after its results
Despite half-yearly results published yesterday evening that confirm solid organic growth, the stock of the Carros-based veterinary laboratory is declining sharply during trading and breaking through an important technical threshold. The SFAF meeting dedicated to financial and strategic information for the first half is taking place today, in a context of pressure on the Paris market.
A 302 € support lost during trading, the share remains below its three moving averages
Virbac is down 5.25% at 298 € during trading, making it the laggard of the SBF 120, an index that itself is declining 0.73%. The price has broken through the 302 € support and remains below it, at 301.50 € at its low, widening a gap of nearly 7% below the MA20 at 319.63 €. The distance to the longer-term moving averages is even more pronounced: the MA50 at 328.11 € is 9.18% above the current price, while the MA200 at 346.96 € is more than 14% away.
This triple bearish gap paints a picture of prolonged pressure, which the RSI at 44 does not yet contradict: the indicator remains in neutral territory, with no sign of selling exhaustion for now. The next major resistance is set at 345 €, which is the zone of longer-term moving averages.
CIC Market Solutions maintains its buy opinion with a target of 400 €, representing 34% of potential
While the share is declining significantly, CIC Market Solutions confirmed today its analyst opinion to buy Virbac, with an unchanged price target of 400 €. At the current price of 298 €, this target represents an upside potential of approximately 34%. The half-yearly publication released on September 17, 2026 — organic growth of 7.4% and annual targets confirmed in the upper end of the range — was not enough to stop the selling pressure.
The monthly decline now stands at 9.42%, in line with a downward trend that has been underway for several weeks. The SFAF meeting today, dedicated to financial and strategic information for the first half, represents the key event for the group; the share remains worth monitoring as it touches the 298 € threshold, which represents a near-term floor following the loss of the 302 € support.
